Unknown

Dataset Information

0

Frequent truncating mutations of STAG2 in bladder cancer.

ABSTRACT: Here we report the discovery of truncating mutations of the gene encoding the cohesin subunit STAG2, which regulates sister chromatid cohesion and segregation, in 36% of papillary non-invasive urothelial carcinomas and 16% of invasive urothelial carcinomas of the bladder. Our studies suggest that STAG2 has a role in controlling chromosome number but not the proliferation of bladder cancer cells. These findings identify STAG2 as one of the most commonly mutated genes in bladder cancer.

SUBMITTER: Solomon DA 

PROVIDER: S-EPMC3875130 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Here we report the discovery of truncating mutations of the gene encoding the cohesin subunit STAG2, which regulates sister chromatid cohesion and segregation, in 36% of papillary non-invasive urothelial carcinomas and 16% of invasive urothelial carcinomas of the bladder. Our studies suggest that STAG2 has a role in controlling chromosome number but not the proliferation of bladder cancer cells. These findings identify STAG2 as one of the most commonly mutated genes in bladder cancer. ...[more]

Similar Datasets

Genomics Frequent truncating mutations of STAG2 in bladder cancer
2013-06-30 | GSE41581 | GEO
Transcriptomics Truncating mutations of STAG2 define a molecular subgroup of aneuploid bladder cancers with poor prognosis.
2013-06-30 | E-GEOD-41581 | biostudies-arrayexpress
Unknown Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes.
| S-EPMC3959811 | biostudies-literature
Unknown Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
| S-EPMC4827439 | biostudies-literature
Unknown Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.
| S-EPMC3840052 | biostudies-literature
Unknown Differential Effects of Clinically Relevant N- versus C-Terminal Truncating CDKN1A Mutations on Cisplatin Sensitivity in Bladder Cancer.
| S-EPMC7925368 | biostudies-literature
Unknown STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
| S-EPMC8286298 | biostudies-literature
Unknown Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
| S-EPMC5373841 | biostudies-literature
Unknown Detectible mosaic truncating PPM1D mutations, age and breast cancer risk.
| S-EPMC8211387 | biostudies-literature
Transcriptomics Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
2013-10-24 | E-GEOD-51641 | biostudies-arrayexpress